Kanagawa, Japan

Tatsuo Kaiho


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Kanagawa, JP (1988 - 1989)
  • Chiba, JP (1993)

Company Filing History:


Years Active: 1988-1993

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Tatsuo Kaiho

Introduction

Tatsuo Kaiho is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 3 patents, his work focuses on developing compounds that have therapeutic effects on the central nervous system.

Latest Patents

One of his latest patents is titled "Catechol derivatives and pharmaceutical preparations containing same." This invention discloses catechol derivatives that produce nerve growth factor in specific brain tissues. These derivatives are designed to provide preventive and therapeutic effects for regressive disorders of the central nervous system, including senile dementia of the Alzheimer type. Another significant patent is for a "Process for preparing 4-acetyl isoquinolinone compounds." This invention relates to a novel process for preparing 4-acetyl-1-methyl-7-pyridyl-5,6,7,8-tetrahydro-3(2H)-isoquinolinone. This compound is particularly useful as a pharmaceutical, especially as a cardiotonic.

Career Highlights

Tatsuo Kaiho is currently associated with Mitsui Toatsu Chemicals, Incorporated, where he continues to innovate in the field of chemical compounds and pharmaceuticals. His work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Throughout his career, Tatsuo has collaborated with notable colleagues, including Nobuyuki Fukazawa and Kengo Otsuka. These collaborations have further enriched his research and development efforts.

Conclusion

Tatsuo Kaiho's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work continues to have a significant impact on the treatment of central nervous system disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…